UNSPSC 51261501: Ancarolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00EED65INL, chemically known as (r,s)-2-(3-(tert-butylamino)-2-hydroxypropoxy-2-furanilid but generally known as ancarolol, which bears US NIH Compound Identifier 170339. European Medicines Agency schedules Ancarolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05506MIG. The term ANCAROLOL is an International Non-Proprietary Name.

UNSPSC 51261501 Ancarolol is a Commodity code that in practice encompasses pharmaceutical products and medical countermeasures for emergency response and public health use. State and local governments procure under this code to stock naloxone, drug deactivation systems, and related emergency medical supplies for community health programs, law enforcement, and opioid-crisis response initiatives. The issuing bodies are typically county health departments and special-purpose public health authorities managing community health infrastructure and emergency preparedness.

Seminole County, Florida represents the recent documented activity under this code, having posted an IFB (Invitation for Bid) on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023. The procurement requires quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. The contract carries an initial two-year term with a one-year renewal option, is potentially funded through FEMA, and includes standard compliance requirements such as E-Verify, drug-free workplace certification, workers' compensation, and commercial general liability insurance. No explicit set-aside or disadvantaged-enterprise designation is mentioned in the solicitation.